EIDD-2801 New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP32744CAS No. ：2349386-89-4Purity：98%

Size	Price	Stock	Quotation Inquiry
100.00 g	Get quote	In-stock	Quotation Inquiry
1.00 kg	Get quote	In-stock	Quotation Inquiry

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	2349386-89-4	Cat. No.	BCP32744
Name	EIDD-2801
Synonyms	EIDD 2801; EIDD2801; Molnupiravir; MK-4482; MK4482; MK 4482; prodrug-EIDD-1931; prodrug-EIDD 1931; prodrug-EIDD1931;
SMILES	O[C@@H]([C@H]([C@H](N1C(N/C(C=C1)=N/O)=O)O2)O)[C@H]2COC(C(C)C)=O
Chemical Name
Formula	C13H19N3O7	M. Wt	329.31
Purity	98%	Storage	Store at 4-8°C
Description	EIDD-2801 is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, EIDD-2801, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus.